|
|
| | Tenofovir prodrug Basic information |
| Product Name: | Tenofovir prodrug | | Synonyms: | 2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, bis(1,1-dimethylethyl) ester, 5-oxide, (R)-;Aids028959;Aids-028959;Bis(T-butyloc)pmpa;Tenofovir prodrug;bis(1-methylethyl) 5-{[(1S)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl}-5-oxo-2,4,6,8-tetraoxa-5-λ5-phosphanonanedioate (tenofovir disoproxil (S)-enantiomer);2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, 1,9-bis(1,1-dimethylethyl) ester, 5-oxide | | CAS: | 201341-01-7 | | MF: | C21H34N5O10P | | MW: | 547.5 | | EINECS: | | | Product Categories: | | | Mol File: | 201341-01-7.mol |  |
| | Tenofovir prodrug Chemical Properties |
| Boiling point | 650.6±65.0 °C(Predicted) | | density | 1.37±0.1 g/cm3(Predicted) | | pka | 4.20±0.10(Predicted) |
| | Tenofovir prodrug Usage And Synthesis |
| | Tenofovir prodrug Preparation Products And Raw materials |
|